Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ Post author:Sam Post published:January 21, 2018 Post category:BioPharma The deal has Sanofi paying $105 per share in cash. Source: BioSpace You Might Also Like Inaugural Asia Pacific GAMP Data Integrity Conference Announced July 16, 2017 <b>Vicarius Pharma</b> Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec August 13, 2017 Cipher Pharma Comments On FDA Warning Letter For ConZip (Tramadol) September 6, 2017
<b>Vicarius Pharma</b> Launches With $21.8 Million and Will be Helmed by Former Biogen-Elan Exec August 13, 2017
